| 证券代码 | MNTA.O |
| 证券名称 | Momenta Pharmaceuticals Inc |
| 证券类型 | 美股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | 主板 |
| 发行方式 | 公开发售 |
| 首发上市日 | 2004-06-22 |
| 首发价格(元) | 6.5 USD |
| 首发数量(股) | 5350000 |
| 首发募资额(元) | 34,775,000.00 USD |
| 首发主承销商 | Banc of America Securities LLC,SG Cowen & Co., LLC |
| 货币单位 | USD |
| 公司名称 | Momenta Pharmaceuticals, Inc. |
| 注册地址 | 美国特拉华州 |
| 办公地址 | 675 West Kendall Street, Cambridge, Massachusetts, USA |
| 成立日期 | 2001-05 |
| 董事会主席 | - |
| 公司属地 | United States 美国 |
| 公司网址 | www.momentapharma.com |
| 电话 | +1 (617) 491-9700 |
| 传真 | +1 (617) 621-0431 |
| 公司简介 | Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the detailed structural analysis of complex drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for autoimmune indications. |